I know this is not a reliable news but someone posted on the yahoo boards a headline from reuters that the drug was rejected.
GNTA high IV
- Thread starter AngusP
- Start date
The news just crossed Reuters. The panel recommended rejection.
http://biz.yahoo.com/rc/040503/health_genta_1.html
Reuters
US FDA panel rejects Genta, Aventis cancer drug
Monday May 3, 11:58 am ET
GAITHERSBURG, Md., May 3 (Reuters) - A U.S. advisory panel on Monday recommended rejection of an experimental cancer drug developed by biotech firm Genta Inc. (NasdaqNM:GNTA - News) and French drug maker Aventis SA (Paris:AVEP.PA - News).
The companies are seeking Food and Drug Administration (News - Websites) clearance to sell the medicine, called Genasense, to treat patients with advanced melanoma, the most deadly form of skin cancer.
US FDA panel rejects Genta, Aventis cancer drug
Monday May 3, 11:58 am ET
GAITHERSBURG, Md., May 3 (Reuters) - A U.S. advisory panel on Monday recommended rejection of an experimental cancer drug developed by biotech firm Genta Inc. (NasdaqNM:GNTA - News) and French drug maker Aventis SA (Paris:AVEP.PA - News).
The companies are seeking Food and Drug Administration (News - Websites) clearance to sell the medicine, called Genasense, to treat patients with advanced melanoma, the most deadly form of skin cancer.
It's still sitting in T2, which is dissemination. Once it goes to T3, there will be a quote time and a release time.
I am reading some stuff that says it isn't quite over for sure just yet, on Yahoo (by a few who know what they are talking about) and in one other place. The uncertainty is over question #3, which speaks to approvability. I wonder if the media jumped the gun?
Stay tuned.
Risk, did you ever sell that stock you bought back at 9.60?